Focus:
Total pharma industry M&A deals in May 2019 worth $9.4bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
Europe's pharma industry saw a drop of 18.5% in deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
Total pharma industry M&A deals in May 2019 worth $2.83bn were announced in the US, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy...
Total pharma industry deals for May 2019 worth $10.66bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
North America's pharma industry saw a drop of 21.6% in deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
The US pharma industry saw a drop of 19.3% in overall deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
Total pharma industry deals for April 2019 worth $7.3bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
North America's pharma industry saw a rise of 5.9% in deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
The US pharma industry saw a rise of 7.5% in overall deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
Total pharma industry M&A deals in April 2019 worth $4.1bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
